Publications
- Lee, Y.H.A., Hui, J.M.H., Chan, J.S.K., Liu, K., Dee, E.C., Ng, K., Tang, P., Tse, G.*, Ng, C.F.* (2022) Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population-based study. The Prostate. PMID: 36178848. https://doi.org/10.1002/pros.24443. Impact factor: 4.0.
- Chan, J.S.K., Lakhani, I., Lee, T.T.L., Chou, O.H.I., Lee, Y.H.A., Cheung, Y.M., Yeung, H.W., Tang, P., Ng, K., Dee, E.C., Liu, T., Wong, W.T., Tse, G.*, Leung, F.P.* (2022) Cardiovascular outcomes and hospitalizations in Asian patients receiving immune checkpoint inhibitors: a population-based study. Current Problems in Cardiology. 101380. PMID: 36031015. https://doi.org/10.1016/j.cpcardiol.2022.101380. Impact factor: 16.4.
- Chan, J.S.K., Tang, P., Hui, J.M.H., Lee, Y.H.A., Dee, E.C., Ng, K., Liu, K., Tse, G.*, Ng, C.F.* (2022) Association between duration of gonadotrophin-releasing hormone agonist use and cardiovascular risks: a population-based competing-risk analysis. The Prostate. PMID: 35915869. https://doi.org/10.1002/pros.24423. Impact factor: 4.0.
- Lee, S., Zhou, J., Lakhani, I., Yang, L., Liu, T., Zhang, Y., Xia, Y., Wong, W.T., Chan, E.W.Y., Wong, I.C.K., Tse, G.*, Zhang, Q.* (2022) Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors and adverse cardiovascular events: a population-based study. Cardio-Oncology. 8(1):5. PMID: 35300724. https://doi.org/10.1186/s40959-021-00128-5.
- Zhang, N, Tse, G., Liu, T. (2021) Neutrophil-lymphocyte ratio in the immune checkpoint inhibitors-related atherosclerosis. European Heart Journal. ehab158. PMID: 33748846. https://doi.org/10.1093/eurheartj/ehab158. 5-year impact factor: 30.1.